Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.62 |
| ▸ | LMNA | P02545 | 7/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 6/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | STAT3 | P40763 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.57 |
| ▸ | RELA | Q04206 | 1/20 | 0.57 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28203320 | 0.98 | TDP1 (0.70) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL327149 | 0.95 | TDP1 (0.70) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL9038339 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL3868979 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL11408718 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL9853336 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL6321085 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL9038701 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL16097150 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 | |
| SCHEMBL4888041 | 0.93 | TDP1 (0.68) | TDP1SMN1; SMN2LMNATSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613365-A1 | MEMBRANES WITH IONIC LIQUIDS FOR CO2 CAPTURE AND DEVICES FOR GAS SEPARATION COMPRISING THEM | Fundació Eurecat (ES) | 2025-09-10 | — | — | EP | claimed |
| CN-115974728-B | Synthesis of phenylsemicarbazone and identification of hexavalent chromium ions by phenylsemicarbazone | 陕西科技大学 | 2024-10-08 | — | — | CN | claimed |
| CN-117777335-B | Expandable polystyrene containing graphite carbon black composite particles and preparation method thereof | 天津嘉泰伟业化工有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117777335-A | Expandable polystyrene containing graphite carbon black composite particles and preparation method thereof | 天津嘉泰伟业化工有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115974728-A | Synthesis of phenyl semicarbazone and identification of hexavalent chromium ions by phenyl semicarbazone | 陕西科技大学 | 2023-04-18 | — | — | CN | claimed |
| CN-111635364-B | Proline ionic liquid and synthesis of catalytic nipagin ester by using same | 陕西科技大学 | 2022-01-25 | — | — | CN | claimed |
| CN-111261414-B | Quasi-solid electrolyte for dye-sensitized solar cell and preparation method thereof | 江苏日御光伏新材料科技有限公司 | 2021-11-05 | — | — | CN | claimed |
| CN-110010356-B | Preparation method of high-conductivity solid electrolyte | 湖南辰砾新材料有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-109545562-B | Solid electrolyte for dye-sensitized solar cell | 新沂市新南环保产业技术研究院有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-111635364-A | Proline ionic liquid and synthesis of catalytic nipagin ester by using same | 陕西科技大学 | 2020-09-08 | — | — | CN | claimed |
| WO-2014167034-A2 | FLUORO AND CHLORO CYANO COMPOUNDS OF THE 15TH GROUP | LONZA LTD (CH) | 2014-10-16 | — | — | WO | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20120157579-A1 | Azolium Ionomer Derivatives of Halogenated Polymers | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2012-06-21 | — | — | US | claimed |
| WO-2012075574-A1 | AZOLIUM IONOMER DERIVATIVES OF HALOGENATED POLYMERS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2012-06-14 | — | — | WO | claimed |
| US-20110214739-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND METHOD OF MANUFACTURING THE SAME, AND ELECTRONIC APPARATUS | SONY CORPORATION (JP) | 2011-09-08 | — | — | US | claimed |
| EP-2363869-A2 | Photoelectric conversion element and method of manufacturing the same, and electronic apparatus | Sony Corporation (JP) | 2011-09-07 | — | — | EP | claimed |
| US-20110100461-A1 | ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL HAVING THE SAME | EVERLIGHT USA, INC. (US) | 2011-05-05 | — | — | US | claimed |
| US-20110100464-A1 | Electrolyte composition and dye-sensitized solar cell using the same | EVERLIGHT USA, INC. (US) | 2011-05-05 | — | — | US | claimed |
| EP-1673348-B1 | BENZOIMIDAZOLE COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2009-04-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | TDP1 3220/4885SMN1; SMN2 4519/4885LMNA 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.